The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Eugene Melnyk speaks during a press conference for Trimel Pharmaceuticals in Toronto, Wednesday, June 25, 2008.
Eugene Melnyk speaks during a press conference for Trimel Pharmaceuticals in Toronto, Wednesday, June 25, 2008.
(Aaron Harris/GLOBE AND MAIL)

Eugene Melnyk pulls off a tricky $150-million refinancing

Eugene Melnyk has finally resolved a complicated debt repayment that engrossed a Canadian pharmaceutical company and a group of sophisticated lenders.

As of Tuesday, CIT Financial Ltd., which worked on behalf of the lending syndicate, said its clients have been repaid in full, and Mr. Melnyk announced that a $150-million refinancing is now in place.